|
Volumn , Issue , 2014, Pages 117-131
|
Progress in the treatment of advanced prostate cancer
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROGEN RECEPTOR;
ANTIANDROGEN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
AR PROTEIN, HUMAN;
RADIOPHARMACEUTICAL AGENT;
ADVERSE EFFECTS;
DRUG EFFECTS;
DRUG RESISTANCE;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
MALE;
METABOLISM;
MORTALITY;
NEOPLASMS, HORMONE-DEPENDENT;
ORCHIECTOMY;
PATHOLOGY;
PROCEDURES;
PROSTATIC NEOPLASMS;
PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
ANDROGEN ANTAGONISTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
IMMUNOTHERAPY;
MALE;
NEOPLASMS, HORMONE-DEPENDENT;
ORCHIECTOMY;
PROSTATIC NEOPLASMS;
PROSTATIC NEOPLASMS, CASTRATION-RESISTANT;
RADIOPHARMACEUTICALS;
RECEPTORS, ANDROGEN;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
|
EID: 84907520518
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.14694/EdBook_AM.2014.34.117 Document Type: Review |
Times cited : (34)
|
References (0)
|